Differences in health care outcomes between postdischarge COPD patients treated with inhaled corticosteroid/long-acting β<sub>2</sub>-agonist via dry-powder inhalers and pressurized metered-dose inhalers
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.